METABOLIC STUDIES WITH A NEW SERIES OF 1,4-DIENE STEROIDS. II. EFFECTS IN NORMAL SUBJECTS OF PREDNISONE, PREDNISOLONE, AND 9α-FLUOROPREDNISOLONE

Clinic of General Medicine and Experimental Therapeutics, National Heart Institute, National Institutes of Health, Bethesda, Md.

Present address: Medical Service, Massachusetts General Hospital, Boston, Mass.

Present address: Harvard University, Cambridge, Mass.

Part of this material has been presented previously (1). The names “metacortandracin” and “metacortandralone” have since been replaced by “prednisone” and “prednisolone.”

Find articles by Pechet, M. in: PubMed | Google Scholar

Clinic of General Medicine and Experimental Therapeutics, National Heart Institute, National Institutes of Health, Bethesda, Md.

Present address: Medical Service, Massachusetts General Hospital, Boston, Mass.

Present address: Harvard University, Cambridge, Mass.

Part of this material has been presented previously (1). The names “metacortandracin” and “metacortandralone” have since been replaced by “prednisone” and “prednisolone.”

Find articles by Bowers, B. in: PubMed | Google Scholar

Clinic of General Medicine and Experimental Therapeutics, National Heart Institute, National Institutes of Health, Bethesda, Md.

Present address: Medical Service, Massachusetts General Hospital, Boston, Mass.

Present address: Harvard University, Cambridge, Mass.

Part of this material has been presented previously (1). The names “metacortandracin” and “metacortandralone” have since been replaced by “prednisone” and “prednisolone.”

Find articles by Bartter, F. in: PubMed | Google Scholar